Drug discovery consulting tailored to your needs

MapleSeed Drug Discovery Consulting

MapleSeed is a Boston-based drug discovery consultancy supporting preclinical research programs with medicinal chemistry from project initiation to the identification of clinical candidates. Offering fractional medicinal chemistry consulting, early-stage companies, biotechs and CROs can receive strategic guidance and support to drive projects across hit finding, hit to lead and lead optimization.

Depending on institution and project stage, different models are available:

-Scientific advisor: building program strategy for early-stage companies with proposed screens, compound library, profiling workflow, path to IP, timelines and resources

-Fractional head of drug discovery: elaborating strategy towards milestones, project team leadership, managing internal and external drug discovery functions, outsourced chemistry, BoD and investor presentations

-Experienced medicinal chemist: performing hit expansion, multi-parameter optimization (potency, selectivity, ADME/PK), compound design, profiling and prioritization, data and SAR analysis, ligand-based and SBDD

-Drug discovery expert for due diligence: reviewing company technology, portfolio and competitive landscape, reviewing development candidate package, compound library

• On-site presence and regular visits available for Boston-based companies

• Each model allows for budget planning with flexibility to quickly increase or reduce bandwidth
  

About the founder